MedPath

甘李药业山东有限公司

Ownership
-
Established
2019-10-25
Employees
-
Market Cap
-
Website
www.111.16.51.26

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Empagliflozin Tablets

Product Name
恩格列净片
Approval Number
国药准字H20253229
Approval Date
Jan 24, 2025
NMPA

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字H20223381
Approval Date
Jun 16, 2022
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath